PMID- 32104785 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220413 IS - 2574-0954 (Electronic) IS - 2574-0954 (Linking) VI - 9 IP - 1 DP - 2020 Mar TI - Effects of aerobic and anaerobic exercise on glucose tolerance in patients with coronary heart disease and type 2 diabetes mellitus. PG - 3-8 LID - 10.1097/XCE.0000000000000188 [doi] AB - In patients with coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM), physical activity is strongly advised as nonpharmacological therapy. In general, a moderate aerobic exercise intensity is recommended. It was also proposed, however, that greater intensities tend to yield even greater benefits in HbA1c. Hence, the most appropriate exercise intensity seems not to be established yet. We compared the effect of moderate (aerobic) and vigorous (anaerobic) activity on postprandial plasma glucose. METHODS: In 10 consecutive patients (63 +/- 12 years, BMI 28.3 +/- 2.6 kg/m(2), fasting plasma glucose 6.1 +/- 1.2 mmol/l), 2-hour plasma glucose was >/=11.1 mmol/l in the oral glucose tolerance test at rest (OGTT-0). Cardiopulmonary exercise test (CPX) was performed until a respiratory exchange ratio (RER) >/=1.20, beeing anaerobic (CPX-1), followed by OGTT-1. A steady-state CPX of 30-minute duration was performed targeting an RER between 0.90 and 0.95, being aerobic (CPX-2), followed by OGTT-2. RESULTS: In CPX-1, maximum exercise intensity (maxIntensity) averaged at 99 +/- 30 Watt and peak oxygen consumption (VO(2peak)) reached 15.9 +/- 2.8 ml/min/kg. In CPX-2, aerobic intensity averaged at 29 +/- 9 Watt, representing 31% of maxIntensity and 61% of VO(2peak). After aerobic exercise, 2-hour plasma glucose was significantly reduced to an average of 9.4 +/- 2.3 mmol/l (P < 0.05). Anaerobic exercise did not reduce 2-hour plasma glucose as compared to OGTT-0 (12.6 +/- 2.2 vs 12.6 +/- 3.9 mmol/l). CONCLUSION: Aerobic exercise intensity was very low in our patients with CHD and T2DM. Postprandial plasma glucose was reduced only by aerobic exercise. Larger studies on the optimal exercise intensity are needed in this patient cohort. CI - Copyright (c) 2019 Wolters Kluwer Health, Inc. All rights reserved. FAU - Schwaab, Bernhard AU - Schwaab B AD - Curschmann Klinik, Rehabilitation Clinic for Cardiology, Angiology and Diabetes, Timmendorfer Strand. FAU - Kafsack, Friderike AU - Kafsack F AD - Curschmann Klinik, Rehabilitation Clinic for Cardiology, Angiology and Diabetes, Timmendorfer Strand. FAU - Markmann, Edith AU - Markmann E AD - Curschmann Klinik, Rehabilitation Clinic for Cardiology, Angiology and Diabetes, Timmendorfer Strand. FAU - Schutt, Morten AU - Schutt M AD - Diabetologische Schwerpunktpraxis, Lubeck, Germany. LA - eng PT - Journal Article DEP - 20200221 PL - United States TA - Cardiovasc Endocrinol Metab JT - Cardiovascular endocrinology & metabolism JID - 101730894 PMC - PMC7041874 OTO - NOTNLM OT - aerobic exercise OT - anaerobic exercise OT - coronary heart disease OT - exercise intensity OT - glucose tolerance OT - type 2 diabetes mellitus COIS- There are no conflicts of interest. EDAT- 2020/02/28 06:00 MHDA- 2020/02/28 06:01 PMCR- 2020/02/21 CRDT- 2020/02/28 06:00 PHST- 2019/08/24 00:00 [received] PHST- 2019/10/22 00:00 [accepted] PHST- 2020/02/28 06:00 [entrez] PHST- 2020/02/28 06:00 [pubmed] PHST- 2020/02/28 06:01 [medline] PHST- 2020/02/21 00:00 [pmc-release] AID - 10.1097/XCE.0000000000000188 [doi] PST - epublish SO - Cardiovasc Endocrinol Metab. 2020 Feb 21;9(1):3-8. doi: 10.1097/XCE.0000000000000188. eCollection 2020 Mar.